Since CAR‐T therapy targeting CD19 had shown high efficiency and might be the only available option for certain patients, this novel treatment has become very important and definitive, especially during the COVID‐19 epidemic.13, 14, 15, 16. This evidence concerns the gene CD19 and COVID-19.